HYBRID EVENT: You can participate in person at Madrid, Spain or Virtually from your home or work.
Madrid, Spain
September 05-07, 2024
ICTM 2024

Rudra Pratap Singh Rajput

Rudra Pratap Singh Rajput, Speaker at Traditional Medicine Conferences
Royal College of Pharmacy, India
Title : Formulation, characterization and evaluation: Micellar loaded complex of cuminum cyminum to treat causing disease of COVID 19 (Respiratory infection)


Background: Corona viruses are a family of viruses that can cause illnesses such as the common cold, Fever, severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), Cancer, Asthma etc.Respiratory infection (RTI) is a viral spreading disease and it transmits from individual to individual, particularly in youngsters and aged peoples. The treatments are available but have so many limitations. To treat RTI, the phyto-constituent antibacterial drug cuminaldehyde (Cuminum Cyminum L.) was selected but it exhibits low bioavailability, poor water-solubility and is rapidly eliminated from the body.
Objectives: To overcome these issues, novel drug delivery (nanoparticle) based micellar loaded complex approach was adopted.
Methods: In this study, the micellar (CM) was prepared by mixing of cuminaldehyde and soya lecithin using anti-solvent precipitation technique and further the micellar loaded complex (CMLC) was prepared by loading of micellar (CM) in aqueous solution of chitosan. The physical compatibility studies by DSC and FT-IR, demonstrated the confirmation of CMLC with soya lecithin and chitosan.
Results: The optimized CMLC and CM were irregular particle shapes and crystalline structures, with a mean particle size of 279.10±0.02 nm, 296.24±0.10 nm and zeta potential of -8.18 mV, -8.77 mV, respectively. The % entrapment efficiency and % drug loading of CMLC (72.13±0.26 %, 06.46±0.01 %) and CM (89.09±0.20%, 08.05±0.19 %) was found efficiently. The in vitro release rate of CM (88.09±0.41 %) was slower than CMLC (89.02±0.06 %) in pH 7.4 phosphate buffer up to 24 h by diffusion process (Korsmeyer Peppas model).
Conclusion: Furthermore, CMLC has shown the potent in vitro antioxidant activity, susceptible antibacterial activity and significant anti-inflammatory activity as compared to CM against stress, microbial infection (S. aureus and E. coli) and inflammation which were causable reason for the respiratory infections. CLMC has shown the significant bioavailability and more efficient hematological parameters value on rabbit blood against the incubation of bacterial organism. CLMC may have the effective potential to treat causing disease of COVID 19 i.e. RTI.

Keywords: Corona virus, Respiratory infection, Micellar Formation, Cuminaldehyde.


Dr. Rudra Pratap Singh Rajput completed Ph.D at JSSAHER, Mysuru (Karnataka) in 2018. Further, He joined as Assistant Professor in Jeypore College of Pharmacy, Odisha in Aug, 2018 and continued his academic profession in Columbia institute of Pharmacy, Raipur since 29th April, 2019 to 17th Feb, 2022. Further He joined to Royal College of Pharmacy, Raipur on 18th Feb, 2022 and continuing till date. He has supervised 8 degree and 7 post graduation students to accomplish project dissertation work. He has more than 33 publication in SCI(E) indexed reputed journals. He also received an international travel grant from ICMR, New Delhi to present his work on international platform. He actively participated in various national and international conferences.